3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Peritoneal Neoplasms
4
Stomach Neoplasms
2
Ovarian Neoplasms
2
Fallopian Tube Neoplasms
2
Appendiceal Neoplasms
2
Wilms Tumor
1
Sarcoma
1
Recurrence
1
Pseudomyxoma Peritonei
1
Hyperthermia
1
Desmoplastic Small Round Cell Tumor
1
Colorectal Neoplasms
1
Carcinoma, Ovarian Epithelial
1
Interventions
Pemetrexed
15
Cisplatin
13
pembrolizumab
6
Platinum
4
1,2-diaminocyclohexaneplatinum II citrate
4
cediranib
3
Radiotherapy
3
Gemcitabine
3
Carboplatin
3
amatuximab
2
Radiotherapy, Intensity-Modulated
2
Radiation
2
Everolimus
2
Drug Therapy
2
Cyclophosphamide
2
tumor necrosis factor-alpha, CNGRC fusion protein, human
1
tremelimumab
1
sodium thiosulfate
1
sargramostim
1
nintedanib
1
napabucasin
1
methoxyamine
1
liposomal doxorubicin
1
incomplete Freund's adjuvant
1
fresolimumab
1
durvalumab
1
defactinib
1
cixutumumab
1
bintrafusp alfa protein, human
1
bemcentinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Mesothelioma, Malignant
×
Hyperthermic Intraperitoneal Chemotherapy
×
Clear all
No trials found.